Testosterone Lawsuit Lawyer –

       Lawyers atandrogel-bottle Matthews & Associates are handling Testosterone Lawsuit claims for men who have suffered heart attack, stroke, deep vein thrombosis, DVT, blood clots or pulmonary embolism after taking prescription testosterone products. Low-T or low testosterone supplements include Androderm, Androgel, Axiron, Bio-T-Gel, Delatestryl, Depo Testosterone, Fortesta, Striant, Testim, Testopel. These FDA-approved products are applied through topical gel, transdermal patch, buccal system (gum), and/or injection.

Free Legal Consultation

Contact a Testosterone Lawyer or a Testosterone Injury Lawyer for a free legal consultation regarding a potential Testosterone Lawsuit or Low-T Lawsuit if you or a loved one has suffered a heart attack, stroke, blood clotting, pulmonary embolism or other serious injury while using topical testosterone supplements. Email us or call us toll free at (888) 520-5202. You may be entitled to compensation for your injuries or those of a loved one. Our Testosterone Lawyers and our experienced legal team can help you pursue the compensation you may deserve.

Testosterone raises Heart Attack, Stroke Risks

A study published in the Nov. 2013 Journal of the American Medical Association (JAMA) found testosterone therapy increases one’s risk of heart attack, stroke, and death. Nine thousand (9,000) male veterans participated in the study. The mean age of the men was 60. All had survived coronary angiography and all had been determined to have low testosterone. About 15% of the men began testosterone therapy. Twenty six (26) percent suffered a heart attack or stroke or died from another cause in a roughly three-year span. In comparing the 26% to the group not taking testosterone therapy, researchers concluded that men on such testosterone medications risk a 30% higher chance of serious, potentially deadly heart issues.

Increase Testosterone Naturally in Minutes?

FDA Safety Alert

Based in part on the November JAMA publication, the FDA announced on Jan. 31, 2014 that it is evaluating the risk of stroke, heart attack and death from testosterone products. In a safety alert the agency said it would reassess the safety of testosterone therapy products. The FDA action was additionally prompted by a study published last month in PLOS ONE regarding testosterone and heart attacks. It showed testosterone therapy for men over 65 doubled their risk of heart attack and tripled the risk of cardio events for men under 65 with pre-existing heart disease.

FDA Approval is Limited

Testosterone products are FDA-approved only for men with low testosterone levels who also have an associated medical condition. These conditions include a failure of testicles to produce testosterone, whether for genetic reasons, chemotherapy poisoning, or some other malady. Brain structure problems can also affect testosterone levels. The hypothalamus or pituitary control production of testosterone in the testicles. The FDA has not approved any of the testosterone products for men with low testosterone who do not have an associated medical condition.

Aggressive Marketing Blitz

Men across the U.S. are being urged by aggressive marketing to seek treatment not only for symptoms of “Low T,” but also low energy, sagging muscles, decreased libido, mood changes, emotional issues, etc. The marketing has worked. Prescriptions for low testosterone (or Low-T) therapy have more than doubled since 2006. In 2011, 5.3 million testosterone prescriptions were written in the U.S. Estimates say 13.8 million American men now experience the effects of lowered testosterone levels.

These products are used by nearly 4% of men in their 60s, but only about half those men actually have hypogonadism, a diminished functional activity of the gonads. Nearly 25% of patients never even had their testosterone levels checked before beginning the therapy.

Side effects and Risks of TRT

Other side effects include enlarged prostate or breasts, blood clots, sleep apnea, liver disease, high cholesterol, blocked arteries. Injuries can occur within 90 days of testosterone therapy.

A Doctor explains Low Testosterone is not so simple

Low T Products – Brand Manufacturers

Androgel – AbbVie Pharmaceuticals

Androderm – Actavis, Inc.

Axiron – Ely Lilly & Company

Bio-T-Gel – Biosante/Teva Pharmaceutical Industries

Delatestryl – Sandoz Canada Inc.

Depo Testosterone – Pfizer Inc.

Foresta – Endo Pharmaceuticals

Striant – Actient Pharmaceuticals

Testim – Auxilium Pharmaceuticals

Testopel – Auxilium Pharmaceuticals

Low T Products – Generic Manufacturers

Testosterone Cypionate – Paddock Laboratories, Inc. (Perrigo Co.)

Testosterone Cypionate – Watson Pharmaceuticals (now Actavis)

 

Testosterone Lawyer for a Low T Lawsuit

Email a Testosterone Lawyer for a free legal consultation regarding a potential Testosterone Injury Lawsuit, Low-T or testosterone therapy claim. Matthews & Associates has tackled Big Pharma for many years. We look forward to working with you, and would be glad to discuss any aspect of this Testosterone litigation.

Related

•  Androgel Low T Lawsuit

•  FDA says Testosterone Labeling needs Update

•  FDA calls for Testosterone Labeling Change

•  FDA: Low T Products must carry Blood Clot Warning

•  Generic Low T Injustice courtesy of Supreme Court

•  Androgel Pay to Delay Lawsuit allowed by Supreme Court

•  Testosterone Lawsuit Lawyer

FacebookTwitterGoogle+Share